January 16, 2025
Headlines

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

Sumain Faisal01 mins

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News